相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot
Claudia Crimi et al.
RESPIRATORY MEDICINE (2021)
Diagnosis and Management of T2-High Asthma
Andrea M. Coverstone et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Effectiveness and safety of benralizumab for severe asthma in clinical practice (J-BEST): a prospective study
Takehiro Izumo et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma
Angela M. Moran et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Exhaled nitric oxide measurements are not influenced by anti-eosinophil therapy in patients with asthma
Richard P. Ramonell et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2020)
Clinical utility of ultrahigh fractional exhaled nitric oxide in predicting bronchial hyperresponsiveness in patients with suspected asthma
Jiaxing Liu et al.
POSTGRADUATE MEDICAL JOURNAL (2019)
Association between exhaled nitric oxide and nasal polyposis in severe asthma
Mauro Maniscalco et al.
RESPIRATORY MEDICINE (2019)
SHOULD FENO BE USED AS A BIOMARKER TO MEASURE RESPONSE TO BENRALIZUMAB?
C. Hsu et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Klaus F. Rabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
M. Castro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Validation of ATS clinical practice guideline cut-points for FeNO in asthma
Maria Jeppegaard et al.
RESPIRATORY MEDICINE (2018)
Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma
Parameswaran Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Recognition and management of severe asthma: A Canadian Thoracic Society position statement
J. Mark FitzGerald et al.
CANADIAN JOURNAL OF RESPIRATORY CRITICAL CARE AND SLEEP MEDICINE (2017)
Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort
Dominick E. Shaw et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Importance of concomitant local and systemic eosinophilia in uncontrolled asthma
Florence Nicole Schleich et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
Sally Wenzel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Exhaled nitric oxide to predict corticosteroid responsiveness and reduce asthma exacerbation rates
James F. Donohue et al.
RESPIRATORY MEDICINE (2013)
Fluticasone/Salmeterol Combination Confers Benefits in People With Asthma Who Smoke
Karine L. Clearie et al.
CHEST (2012)
Asthma outcomes: Biomarkers
Stanley J. Szefler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Exhaled Nitric Oxide Measurement in Patients Affected by Nasal Polyposis
Jacopo Galli et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2012)
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications
Raed A. Dweik et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Pranabashis Haldar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma
Patrick Flood-Page et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
分享论文
